DermBiont
PrivateLast Round
Series B
Oct 24, 2023
Total Funding Raised
$76.65M
Company Overview
DermBiont is a biotechnology company that develops targeted topical therapeutics for rare disease oncology and aesthetic dermatology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DermBiont Comparables
Compare DermBiont with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PellePharm | 88% | |
| NFlection Therapeutics | 84% | |
| AOBiome Therapeutics Inc. | 78% | |
DermBiont Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 24, 2023 | ||||
| Debt | Mar 28, 2023 | ||||
| Series A Extension | Dec 21, 2021 | ||||
| Series A | Jun 18, 2019 | ||||
| Accelerator | Apr 26, 2018 |
DermBiont Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Viking Global Investors | Series B, Series A Extension, Series A |
| Toba Capital | Series A Extension, Series A |
| Zola Global | Series A |
| Pivotal bioVenture Partners | Series A Extension |
| Civilization Ventures | Series B, Series A Extension |
| Double Point Ventures | Series B |
| Illumina Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 44% MoM, reaching 1.3K.
- Dec 21, 2021
$28M round led by Pivotal bioVenture Partners.
DermBiont Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DermBiont's valuation, stock price, and market status.